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carcinomas both in vivo and in vitro.2
Lung cancer cells express both  and 
ER; the former, which seems to occur
more often in the lung of women than men
is localized in the cytoplasm, the latter in
the nucleus. Interesting data, regarding the
intense crosstalk between ERs and growth
factor such as EGF, are emerging.3–5
Direct binding of the ligand-ER
complex with steroid receptor coactivators
and estrogen receptor elements in DNA
leads to change in gene transcription that
regulate growth, differentiation, apoptosis,
and angiogenesis. Alternative pathways
may be activated by estrogen without di-
rect ER binding to DNA or by kinases
associated to epidermal growth factor re-
ceptor in the absence of estrogens. Many
rapid effects of estrogens may be also due
to activation of extranuclear signaling
pathways that are mediated by cell-surface
forms of ERs.
The interaction between ER and
EGFR/HER2 is demonstrated in NSCLC
cell lines as the treatment with estradiol
resulted in down-regulation of EGFR,
whereas treatment with the antiestrogen
fulvestrant increased the EGFR expres-
sion. In fact the combination of fulves-
trant and gefitinib in NSCLC may in-
hibit cell proliferation, induce apoptosis
and affect downstream signaling path-
ways. Moreover, ER  expression is
decreased in response to EGF and in-
creased in response to gefitinib.5
The recent evidence of crosstalk
between the EGFR and ER pathways,
along with the striking efficacy of ty-
rosine kinase inhibitors in women with
lung cancer and the emerging role of
estrogens in lung tumorigenesis, pro-
vides rationale to examine drugs that
target these two pathways for lung can-
cer treatment in selected patients.
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Use of Fluoroscopy
During Endobronchial
Ultrasonography for
Transbronchial Lung
Biopsies of Peripheral
Lung Lesions
To the Editor:
Fluoroscopic guidance in the per-
formance of transbronchial biopsies is
known to increase diagnostic yield by
allowing biopsies to accurately target
the area of interest.1 Diagnostic yields
have increased further with the introduc-
tion of Endobronchial Ultrasound using
Guide Sheath (EBUS-GS), with initial
reports utilizing fluoroscopic guidance
during the procedure.2 Recent reports
have suggested Endobronchial Ultra-
sound (EBUS) may be performed with-
out fluoroscopy.3 However, the authors
of this study noted a lower yield in
lesions in the right lower lobe, and at-
tributed this to movement of the probe
as a result of deep respiration. Dooms et
al.4 recently described the use of EBUS
bronchoscopy in bronchoscopically oc-
cult pulmonary lesions and noted that
for potentially fluoroscopically visible le-
sions (2 cm) no size difference was
noted between successfully diagnosed le-
sions and undiagnosed ones, suggesting
that further increasing accurate localiza-
tion of lesions using fluoroscopy may
have resulted in a further improved yield.
Our experience is that fluoroscopy is a
valuable tool in the performance of
EBUS-GS bronchoscopy as it is able to
confirm immediately before each biopsy
that specimens are taken from the area of
interest.
In support of this, we report a
60-year-old man, current smoker who
presented for bronchoscopy for investi-
gation of an incidental 2.6 cm right mid-
dle lobe nodule on computed tomogra-
phy chest (see Figure 1). Normal
endobronchial examination was fol-
lowed by EBUS-GS examination that
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FIGURE 1. CT chest demonstrating right middle lobe mass with dual “bronchus
sign” (arrow).
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demonstrated a right middle lobe solid
lesion (Figure 2). As previously de-
scribed,2 the probe was removed after
localization of the procedure, leaving
the guide sheath in place. Three trans-
bronchial lung biopsies under fluoro-
scopic guidance were performed via the
guide sheath. Fluoroscopic screening is
performed during each biopsy to con-
firm, firstly, that the sheath remains in
its original position and, secondly, that
the biopsy forceps have passed the cor-
rect distance into the lung periphery.
Screening for performance of a fourth
biopsy suggested the guide sheath had
moved into an adjacent bronchus (Fig-
ure 3). Repeat EBUS examination dem-
onstrated that although the probe was
positioned in a different bronchus, the
solid mass could still be visualized. Fur-
ther biopsies were performed. Histo-
logic examination confirmed bronchoal-
veolar carcinoma.
Our case demonstrates the value of
fluoroscopy in performance of EBUS-GS
bronchoscopy. The two EBUS images ob-
tained are consistent with the probe being
in different bronchial segments. This is
not surprising as on computed tomogra-
phy chest there is clearly a dual “bronchus
sign” seen. Had fluoroscopy not been
used, we would have been unaware of the
inadvertent repositioning of the guide
sheath. This clearly has the potential to
compromise diagnostic yield of the proce-
dure. Even movement to a bronchus adja-
cent to a mass may compromise diagnos-
tic yield.5
There is potential for movement of
the probe after deployment in any lobe
due to deep respiration or vigorous cough-
ing. Given performance of EBUS-GS is
not a real-time procedure, we feel its op-
timal performance in the investigation of
peripheral pulmonary lesions is aided by
fluoroscopic guidance, as illustrated by
this case.
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FIGURE 2. Endobronchial ultrasound image initially demonstrated in right mid-
dle lobe. Arrows mark the border of the lesion, with the ultrasound probe posi-
tioned in the middle of the lesion.
FIGURE 3. Endobronchial ultrasound image seen subsequent to fluoroscopic
demonstration of relocation of guide sheath. Ultrasound probe is now situated at
periphery of lesion (arrow), as opposed to centrally (as seen in Figure 2).
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